Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Biomaterials Science

Background:

• Diseased host milieu, characterized by endothelial dysfunction (ED), low nitric oxide (NO) bioavailability, and post-myocardial infarction (MI) inflammation, impedes cardiac regenerative therapies.
• Existing cell therapies often yield disappointing results in human studies due to the unfavorable cardiac environment.

Purpose of the Study:

• To review current pharmacological and nonpharmacological strategies for improving the diseased host milieu in cardiovascular disease.
• To focus on the mechanisms of ED, efficacy of ED-improving strategies, and the role of biomaterials in modulating the post-MI environment.

Main Methods:

• Review of pre-clinical and clinical studies on strategies to improve endothelial function.
• Analysis of the mechanisms underlying endothelial dysfunction in cardiovascular diseases.
• Evaluation of biomaterials as modulators of the damaged post-myocardial infarction environment.

Main Results:

• Adjunct therapies targeting host endothelial function demonstrate promising outcomes in improving cardiac regeneration.
• Biomaterials offer a novel approach to modulate the damaged cardiac environment post-MI.

Conclusions:

• Improving the host milieu, particularly endothelial function, is essential for enhancing the success of cardiac regenerative therapies.
• Future research should focus on understanding host-tissue interactions and signaling pathways to optimize regenerative strategies.
• Further investigation into the safety and efficacy of these adjunct therapies is required for widespread clinical application.